LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
57 hedge funds and large institutions have $73.2M invested in LogicBio Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
75% less call options, than puts
Call options by funds: $14K | Put options by funds: $57K
Holders
57
Holding in Top 10
–
Calls
$14K
Puts
$57K
Top Buyers
| 1 | +$1.6M | |
| 2 | +$1.47M | |
| 3 | +$458K | |
| 4 |
SC
Samlyn Capital
New York
|
+$246K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$110K |
Top Sellers
| 1 | -$845K | |
| 2 | -$433K | |
| 3 | -$340K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$254K |
| 5 |
Renaissance Technologies
New York
|
-$226K |